Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1007/s00296-017-3679-4
Published Online: 2017-03-02
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schenfeld, Jennifer
Iles, Jan
Trivedi, Mona
Accortt, Neil A.
Funding for this research was provided by:
Immunex, a wholly owned subsidiary of Amgen Inc.
License valid from 2017-03-02